ALLIANCEBERNSTEIN L.P. - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$136,900
+66.7%
74,0000.0%0.00%
Q4 2022$82,140
-48.0%
74,000
+9.5%
0.00%
Q3 2022$158,000
-19.8%
67,600
+3.8%
0.00%
Q2 2022$197,000
-53.3%
65,100
+4.8%
0.00%
Q1 2022$422,000
-18.4%
62,100
+0.3%
0.00%
Q4 2021$517,000
+12.4%
61,9000.0%0.00%
Q3 2021$460,000
+9.3%
61,9000.0%0.00%
Q2 2021$421,000
-26.7%
61,900
+10.7%
0.00%
Q1 2021$574,000
+46.8%
55,9000.0%0.00%
Q4 2020$391,000
-14.3%
55,9000.0%0.00%
Q3 2020$456,000
+16.9%
55,900
-1.1%
0.00%
Q2 2020$390,000
+63.9%
56,500
+12.5%
0.00%
Q1 2020$238,000
-35.3%
50,200
+19.2%
0.00%
Q4 2019$368,000
+162.9%
42,1000.0%0.00%
Q3 2019$140,000
-32.7%
42,1000.0%0.00%
Q2 2019$208,000
-18.8%
42,100
+1.9%
0.00%
Q1 2019$256,000
+84.2%
41,3000.0%0.00%
Q4 2018$139,000
-48.1%
41,3000.0%0.00%
Q3 2018$268,000
-11.8%
41,300
+4.0%
0.00%
Q2 2018$304,000
-23.6%
39,700
+123.0%
0.00%
Q1 2018$398,000
+130.1%
17,800
+30.9%
0.00%
Q4 2017$173,000
-11.7%
13,600
+7.9%
0.00%
Q3 2017$196,000
+10.7%
12,6000.0%0.00%
Q2 2017$177,00012,6000.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TRV GP II, LLC 9,200,349$64,402,00044.86%
TRV GP III, LLC 3,048,780$21,342,0001.83%
SILVERARC CAPITAL MANAGEMENT, LLC 406,665$2,847,0001.65%
Sofinnova Investments, Inc. 925,280$6,477,0000.39%
Omega Fund Management, LLC 334,965$2,345,0000.35%
Yorktown Management & Research Co Inc 49,200$344,0000.31%
Woodline Partners LP 940,902$6,586,0000.18%
HUSSMAN STRATEGIC ADVISORS, INC. 51,000$357,0000.09%
HORIZON FINANCIAL SERVICES, LLC 12,005$84,0000.08%
Gyon Technologies Capital Management, LP 26,893$188,0000.06%
View complete list of JOUNCE THERAPEUTICS INC shareholders